← Eichor
Study identifier: NCT06662747 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Vaginal Microbiome Research Consortium for Africa

Condition: Healthy  ·  Sponsor: University of Cape Town

PhaseN/A
Planned participants200
Who can joinFemale, 18 Years to 40 Years
Healthy volunteersYes

About this study

1. To characterise vaginal microbial community dynamics (bacterial and fungal) from different geographies in Africa to understand the microbial diversity that occurs in women with stable L. crispatus-dominant versus unstable vaginal microbiota. 2. To identify vaginal communities associated with low levels of inflammation in women from different geographies in Africa 3. To examine prevalence and diversity of HPV types circulating in the different geographies and their interaction with the vaginal microbiota 4. To create a biobank of stored samples that can be used in future studies and for the isolation of regionally representative bacterial strains.

This description comes directly from the study's public registry record.

Talk to the study team

Jo-Ann S Passmore, PhD  ·  +27 78 421 2701  ·  jo-ann.passmore@uct.ac.za

Tanya Pidwell, MSc Hons  ·  +27 82 725 5159  ·  tanya.pidwell@uct.ac.za

Always discuss trial participation with your own doctor first.

Locations (2)

KEMRIKisumu, Kisumu County, KenyaRecruiting
Desmond Tutu Health FoundationCape Town, Western Cape, South AfricaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06662747